Description
Recombinant monoclonal antibody to CD45R. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma RA3-6B2.
Target
CD45R
Target Alias Names
B220, CD45, CD45 antigen, Cluster designation 45R, L-CA, Leukocyte common antigen, Ly-5, lymphocyte antigen 5, lymphocyte common antigen, Lyt-4, protein tyrosine phosphatase, receptor type, C, protein tyrosine phosphatase, receptor type, c polypeptide, Receptor-type tyrosine-protein phosphatase C, T200, T200 glycoprotein, T200 leukocyte common antigen
Isotype/Mimetic
IgG2a
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression